Answers are grounded in this paper and cite their sources.
Case-control study evaluates genetic factors influencing pterygium risk, highlighting immune pathway roles.
Background/Aim: Pterygium is a common ocular surface disorder with multifactorial etiology involving environmental exposure and immune dysregulation. Interleukin-12 (IL-12), a key immunomodulatory cytokine, has been implicated in inflammation and tumor-related processes, yet its genetic contribution to pterygium remains unclear. This study aimed to evaluate the association between IL-12A polymorphisms and pterygium susceptibility. Materials and Methods: A hospital-based case-control study was conducted, including 160 pterygium patients and 320 age- and sex-matched controls. Genotyping of IL-12A rs568408 and rs2243115 was performed via restriction fragment length polymorphism methods. Results: Both polymorphisms were in Hardy-Weinberg equilibrium among controls (p=0.2165 and p=0.5533). No significant differences in genotype distributions were observed between cases and controls for rs568408 (p for trend=0.5727) or rs2243115 (p for trend=0.5471). The rs568408 AG and AA genotypes showed non-significant associations with pterygium risk (OR=1.14, 95%CI=0.72-1.78, p=0.6603; OR=1.63, 95% CI=0.59-4.49, p=0.4950). Similarly, allelic analyses revealed no significant associations (as for rs568408, OR=1.21, 95%CI=0.84-1.76, p=0.3527; as for rs2243115, OR=1.27, 95%CI=0.81-2.01, p=0.3581). Conclusion: Despite the tumor-like and inflammatory characteristics of pterygium, IL-12A polymorphisms were not significantly associated with disease susceptibility. However, IL-12-mediated immune pathways may still contribute to disease pathogenesis through functional regulation rather than genetic variation. Further large-scale and mechanistic studies are warranted.
No takes yet. Share an insight, caveat, or question.
YANG et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: